Sydney-based start-up E-Nome has signed a strategic alliance with the Garvan Institute of Medical Research to explore the application of its blockchain-enabled health record management platform to clinical trials and medical research.

The firm has also invested in fellow start-up Tyde, a registered portal operator for the My Health Record, and plans to use its technology to deliver MyHR content into the E-Nome platform with ambitious plans of having 50 per cent of Australians with a My Health Record also using the platform by 2020.

E-Nome, which is led by former Garvan Institute and St Vincent's & Mater Health director Nick Curtis and which recruited former St Vincent's Hospital CIO David Roffe in February, also plans to build APIs to link its platform to medical practice management systems and to launch its system to the public next September.